Literature DB >> 30738712

The influence of lymph node ratio on survival and disease recurrence in squamous cell carcinoma of the tongue.

L Hingsammer1, T Seier2, J Ikenberg3, P Schumann2, D Zweifel2, M Rücker2, M Bredell2, M Lanzer2.   

Abstract

This study was performed to report the outcomes of patients with oral squamous cell carcinoma (OSCC) of the tongue over a 10-year period with the aim of testing the hypothesis that the lymph node ratio (LNR) has a significant influence on loco-regional recurrence. The charts of 227 patients with OSCC of the mobile tongue treated at the University Hospital of Zurich from 2003 to 2012 were screened. Following the application of the exclusion criteria (prior chemotherapy, radiotherapy, or surgery, perioperative death, N3 disease, unresectable disease, synchronous second primary, no signed informed consent, and follow-up <3years), prospective data were collected and a retrospective analysis performed for 88 of these patients who were treated with selective neck dissection. During a mean follow-up period of 78 months (standard deviation 37 months), loco-regional recurrence was diagnosed in 25 patients (28%). The overall and disease-specific survival rates for the study population were 72% and 80%, respectively. Perineural invasion was identified as an independent risk factor for decreased disease-specific survival, whereas LNR was not. LNR did not show an influence on disease recurrence. Thus, its prognostic value in patients with tongue cancer remains uncertain and the decision regarding adjuvant therapy should not be made solely on the basis of LNR.
Copyright © 2019 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  head and neck cancer; neck dissection; survival rate; tongue cancer

Mesh:

Year:  2019        PMID: 30738712     DOI: 10.1016/j.ijom.2019.01.008

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  5 in total

1.  C-reactive protein promotes tongue squamous cell carcinoma chemoresistance by inhibiting the activation of caspase-3/9 via the CD64/AKT/mTOR pathway.

Authors:  Shenglin Wang; Qinchao Chen; Xiaodong Yan; Meng Cao; Zhigang Wang
Journal:  Hum Cell       Date:  2021-05-21       Impact factor: 4.174

2.  A Combined Prediction Model for Lymph Node Metastasis Based on a Molecular Panel and Clinicopathological Factors in Oral Squamous Cell Carcinoma.

Authors:  Shu Wang; Tiancheng Li; Huan Liu; Wei Wei; Yang Yang; Chong Wang; Bo Li; Zhengxue Han; Zhien Feng
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

Review 3.  Adding Concomitant Chemotherapy to Postoperative Radiotherapy in Oral Cavity Carcinoma with Minor Risk Factors: Systematic Review of the Literature and Meta-Analysis.

Authors:  Alessia Di Rito; Francesco Fiorica; Roberta Carbonara; Francesca Di Pressa; Federica Bertolini; Francesco Mannavola; Frank Lohr; Angela Sardaro; Elisa D'Angelo
Journal:  Cancers (Basel)       Date:  2022-07-29       Impact factor: 6.575

Review 4.  STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma.

Authors:  Mingjing Jiang; Bo Li
Journal:  Cells       Date:  2022-10-05       Impact factor: 7.666

5.  TUG1/miR-133b/CXCR4 axis regulates cisplatin resistance in human tongue squamous cell carcinoma.

Authors:  Ke Zhang; Hong Zhou; Bo Yan; Xuanping Cao
Journal:  Cancer Cell Int       Date:  2020-05-06       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.